Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 1/20 | 0.43 |
| ▸ | CCR8 | P51685 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4024459 | 0.98 | CYP11B1 (0.51) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL23351094 | 0.95 | CYP11B1 (0.47) | CYP11B1CYP11B2MEN1MAPTKMT2A | |
| SCHEMBL8024916 | 0.79 | MAOA (0.53) | KCNH2 | |
| SCHEMBL30833268 | 0.78 | ASIC3 (0.49) | HTR1AHTR7 | |
| SCHEMBL1010747 | 0.78 | ASIC3 (0.56) | HTR1AHTR7 | |
| SCHEMBL5713849 | 0.78 | PDK2 (0.42) | SMN1; SMN2TP53ALOX15KDM4ELMNA | |
| SCHEMBL1011236 | 0.78 | ASIC3 (0.49) | HTR1AHTR7 | |
| SCHEMBL30641498 | 0.76 | MAOA (0.49) | PDK2CNR2NPY5RCYP2A6CREBBP | |
| SCHEMBL5713852 | 0.76 | PDK2 (0.38) | MAPTSMN1; SMN2ALDH1A1TP53ALOX15 | |
| SCHEMBL21810824 | 0.76 | RIPK1 (0.56) | MAPTSMN1; SMN2NPC1TP53RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598879-B1 | LUMINESCENCE DEVICE, DISPLAY APPARATUS AND METAL COORDINATION COMPOUND | CANON KK (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-7534506-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7026062-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2006-04-11 | — | — | US | disclosed |
| EP-1191613-B1 | Luminescence device, display apparatus and metal coordination compound | CANON KK (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20060014047-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2006-01-19 | — | — | US | disclosed |
| EP-1598879-A2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-20050014025-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2005-01-20 | — | — | US | disclosed |
| US-6815091-B2 | IRIDIUM, RHODIUM, OR PALLADIUM-PHENYLPYRIDINE COMPLEX WITH SPECIFIED SUBSTITUENT(S); HIGH-EFFICIENCY LUMINESCENCE, HIGH BRIGHTNESS FOR A LONG TIME WHILE MINIMIZING DETERIORATION IN LUMINESCENCE IN ENERGIZED STATE | CANON KABUSHIKI KAISHA (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20020064681-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-1191613-A2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014047-A1 | Luminescence device, display apparatus and metal coordination compound | SOD1, ICOSLG, CCRL2 | CYP11B1 3018/4885CYP11B2 2617/4885MEN1 1695/4885 |
| US-20020064681-A1 | Luminescence device, display apparatus and metal coordination compound | CDYL, ZC3HAV1L, ICOSLG | CYP11B1 1770/4885CYP11B2 1463/4885MEN1 2212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.